Neurological aspects of multiple myeloma and related disorders

Angela Dispenzieri1, Robert A Kyle

  • 1Mayo Clinic, Medicine, Rochester, Minnesota MN 55905, USA. dispenzieri.angela@mayo.edu

Insights

Neurologic complications in multiple myeloma (MM) and related disorders vary widely, including compression, infiltration, metabolic issues, and autoimmune responses. This review covers MM, MGUS, WM, POEMS syndrome, amyloidosis, and cryoglobulinemia.

Area of Science:

  • Neurology
  • Hematology
  • Oncology

Background:

  • Multiple myeloma (MM) and related plasma cell dyscrasias present with a broad spectrum of neurologic complications.
  • These complications arise from various mechanisms including direct compression, tumor infiltration, metabolic disturbances, and immune-mediated processes.

Purpose of the Study:

  • To comprehensively review the diverse neurologic complications associated with multiple myeloma (MM).
  • To discuss neurologic manifestations in related conditions such as monoclonal gammopathy of undetermined significance (MGUS), Waldenström macroglobulinemia (WM), POEMS syndrome, amyloidosis, and cryoglobulinemia.

Main Methods:

  • Literature review of neurologic complications in MM and related disorders.
  • Categorization of complications by underlying mechanism (compressive, infiltrative, metabolic, autoimmune).

Main Results:

  • Compressive radiculopathy is a common presentation in MM.
  • Peripheral neuropathies are frequently observed in various related disorders.
  • Other complications include spinal cord compression, base-of-the-skull tumors, amyloid infiltration, numb chin syndrome, slowed mentation, and autoimmune neuropathies.

Conclusions:

  • Neurologic complications are a significant clinical challenge in MM and associated plasma cell disorders.
  • Understanding the diverse mechanisms is crucial for accurate diagnosis and management.
  • This review provides a framework for recognizing and addressing these neurologic issues across a spectrum of hematologic malignancies.

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Disorders of the Nervous Tissue01:28

Disorders of the Nervous Tissue

Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...